By Jenny Ruth
Friday 11th December 2009 |
Text too small? |
Insurance company Tower's stronger-than-expected annual result had led him to upgrade his 2010 net profit forecast by 15.6% to $54.6 million and his valuation from $1.98 per share to $2.30, says Forsyth Barr analyst John Cairns.
"Over 2009, Tower experienced strong growth in individual and group life premiums, both in new business and in-force business volumes," Cairns says.
After-tax earnings from its health business near doubled to $10.9 million due to improved underwriting margins, he says.
Its general insurance underwriting result was up 36% to $14.1 million, driven by increased premiums and reduced claims cost.
Its funds under management grew 6% in the second half but were down 3.5% over the full year. Profit from investments rose 57% to $5.8 million.
"Tower is continuing to make operational improvements across its three business units," Cairns says. "Tower is in a robust financial position, capable of executing value-accretive acquisitions to build scale in its core existing business units," he says.
Any acquisition risk is mitigated by the involvement of Tower's 35% shareholder, Guinness Peat Group, he says. After its recent capital raising, Tower has $66 million in net cash.
Cairns expects Tower will target gearing between 20% and 30%, "implying potential acquisitions of around $200 million."
BROKER CALL: Forsyth Barr rate Tower as accumulate.
No comments yet
Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy